A new approach to the anticancer drug Velcade was developed by performing asymmetric borylation of an imine anchored with a chiral N-phosphinyl auxiliary. Throughout the 7-step synthesis, especially in the imine’s synthesis and in the asymmetric borylation reactions, operations and work-up were conducted in simple and easy ways without any column chromatographic purification, which defines the GAP (group-assisted purification) chemistry concept. It was found that the optically pure isomer (dr > 99:1) can be readily obtained by washing the crude mixture of the asymmetric borylation reaction with hexane; the chiral N-phosphinyl auxiliary can be easily recovered after deprotection is finished. Several other N-phosphinylimines were also investigated for the asymmetric borylation reaction. The absolute configuration of the borylation product was confirmed by single crystal X-ray diffraction analysis.
通过使用带手性N-膦辅助基的
缩醛进行不对称
硼化反应,开发了一种新的抗癌药物Velcade的方法。在整个7步合成中,特别是在
缩醛的合成和不对称
硼化反应中,操作和工作都是简单易行的,没有进行任何柱层析纯化,这定义了GAP(群辅助纯化)
化学概念。发现通过用
正己烷洗涤不对称
硼化反应的混合物可以轻松地得到光学纯异构体(dr>99:1);在去保护作用完成后,手性N-膦辅助基可以轻松地回收。还研究了几种其他的N-膦
缩醛用于不对称
硼化反应。通过单晶X射线衍射分析确定了
硼化产物的绝对构型。